Evidence map›Paper›PMID 41036017›Full record

ArticleOpen veterinary journal2025

Host-parasite interaction in latent cerebral toxoplasmosis: The role of cytokine response in a mouse model.

Tuğçe Anteplioğlu, Merve Bişkin Türkmen, Erva Eser, Damla Okatan, Oğuz Kul

Abstract read
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tuğçe AnteplioğluDepartment of Pathology, Faculty of Veterinary Medicine, Kırıkkale University, Kırıkkale, Turkey.
Merve Bişkin TürkmenDepartment of Pathology, Faculty of Veterinary Medicine, Kırıkkale University, Kırıkkale, Turkey.
Erva EserDepartment of Biostatistics, Faculty of Veterinary Medicine, Kırıkkale University, Kırıkkale, Turkey.
Damla OkatanDepartment of Pathology, Faculty of Veterinary Medicine, Kırıkkale University, Kırıkkale, Turkey.
Oğuz KulDepartment of Pathology, Faculty of Veterinary Medicine, Kırıkkale University, Kırıkkale, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Aim: This study aimed to evaluate infection severity, affected immune cell populations, and cytokine response in both early and late chronic phases of T. gondii infection. Methods: A murine model was developed by infecting C57BL/6 mice with a sub-infective dose (104 tachyzoites) of the ME49 strain. Forty mice were used: 30 infected and 10 controls. Animals were sacrificed on days 30, 60, and 180 after infection. Brains were analyzed using histopathology, immunohistochemistry, and nested polymerase chain reaction (PCR). Results: Histopathological changes, including gliosis, meningitis, vasculitis, and neuronal degeneration, were most prominent on days 30 and 60 and decreased by day 180. Immunohistochemistry revealed dynamic changes in immune cell populations (CD4 Conclusion: This model shares several immunopathological features with chronic cerebral toxoplasmosis observed in immunocompetent humans, modeling aspects of the infection even in the absence of demonstrable tissue cysts. The immunological shift from pro-inflammatory to regulatory responses highlights the mechanisms of immune modulation and persistence. This study provides a useful platform to explore host-pathogen interactions and CNS immune dynamics in chronic cerebral toxoplasmosis.

Indexed as

CytokinesHost-Parasite InteractionsToxoplasmaToxoplasmosis, AnimalToxoplasmosis, CerebralAnimalsBrainDisease Models, AnimalFemaleMiceMice, Inbred C57BLCytokinesBrain diseaseCytokineImmunohistochemistryMiceToxoplasma gondii

Identifiers

PMID41036017
PMCPMC12483481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.